OpenURL Connection Search

Select item for more details and to access through your institution.

Collaborative study from the Bladder Cancer Advocacy Network for the genomic analysis of metastatic urothelial cancer.
Published in:
Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-33980-9
By:
- Damrauer, Jeffrey S.;
- Beckabir, Wolfgang;
- Klomp, Jeff;
- Zhou, Mi;
- Plimack, Elizabeth R.;
- Galsky, Matthew D.;
- Grivas, Petros;
- Hahn, Noah M.;
- O'Donnell, Peter H.;
- Iyer, Gopa;
- Quinn, David I.;
- Vincent, Benjamin G.;
- Quale, Diane Zipursky;
- Wobker, Sara E.;
- Hoadley, Katherine A.;
- Kim, William Y.;
- Milowsky, Matthew I.
Publication type:
Article
Results From a Randomized Phase II Trial of Sunitinib and Gemcitabine or Sunitinib in Advanced Renal Cell Carcinoma with Sarcomatoid Features: ECOG-ACRIN E1808.
Published in:
Clinical Genitourinary Cancer, 2023, v. 21, n. 5, p. 546, doi. 10.1016/j.clgc.2023.06.012
By:
- Carthon, Bradley C.;
- Se Eun Kim;
- McDermott, David F.;
- Dutcher, Janice P.;
- Puligandla, Maneka;
- Manola, Judith;
- Pins, Michael;
- Carducci, Michael A.;
- Plimack, Elizabeth R.;
- Appleman, Leonard J.;
- MacVicar, Gary R.;
- Kohli, Manish;
- Kuzel, Timothy M.;
- DiPaola, Robert S.;
- Haas, Naomi B.
Publication type:
Article
Treatment of Metastatic Urothelial Carcinoma After Previous Cisplatin-based Chemotherapy for Localized Disease: A Retrospective Comparison of Different Chemotherapy Regimens.
Published in:
Clinical Genitourinary Cancer, 2021, v. 19, n. 2, p. 125, doi. 10.1016/j.clgc.2020.10.006
By:
- Do, Olivia A.;
- Ferris, Lorin A.;
- Holt, Sarah K.;
- Ramos, Jorge D.;
- Harshman, Lauren C.;
- Plimack, Elizabeth R.;
- Crabb, Simon J.;
- Pal, Sumanta K.;
- De Giorgi, Ugo;
- Ladoire, Sylvain;
- Baniel, Jack;
- Necchi, Andrea;
- Vaishampayan, Ulka N.;
- Bamias, Aristotelis;
- Bellmunt, Joaquim;
- Srinivas, Sandy;
- Dorff, Tanya B.;
- Galsky, Matt D.;
- Yu, Evan Y.
Publication type:
Article
Targeting Signaling Transduction Pathways in Bladder Cancer.
Published in:
Current Oncology Reports, 2015, v. 17, n. 12, p. 1, doi. 10.1007/s11912-015-0477-6
By:
- Abbosh, Phillip H.;
- McConkey, David J.;
- Plimack, Elizabeth R.
Publication type:
Article
Potential role of <sup>124</sup>I-girentuximab in the presurgical diagnosis of clear-cell renal cell cancer.
Published in:
Biologics: Targets & Therapy, 2012, v. 6, p. 395, doi. 10.2147/BTT.S30413
By:
- Smaldone, Marc C.;
- Chen, David Y. T.;
- Yu, Jian Q.;
- Plimack, Elizabeth R.
Publication type:
Article
Role of immunotherapy in localized muscle invasive urothelial cancer.
Published in:
Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211045858
By:
- Kaur, Jasmeet;
- Choi, Woonyoung;
- Geynisman, Daniel M.;
- Plimack, Elizabeth R.;
- Ghatalia, Pooja
Publication type:
Article
Role of immunotherapy in localized muscle invasive urothelial cancer.
Published in:
Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211045858
By:
- Kaur, Jasmeet;
- Choi, Woonyoung;
- Geynisman, Daniel M.;
- Plimack, Elizabeth R.;
- Ghatalia, Pooja
Publication type:
Article
Epacadostat plus pembrolizumab versus placebo plus pembrolizumab for advanced urothelial carcinoma: results from the randomized phase III ECHO-303/KEYNOTE-698 study.
Published in:
BMC Cancer, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11213-6
By:
- Cicin, Irfan;
- Plimack, Elizabeth R.;
- Gurney, Howard;
- Leibowitz, Raya;
- Alekseev, Boris Y.;
- Parnis, Francis X.;
- Peer, Avivit;
- Necchi, Andrea;
- Bellmunt, Joaquim;
- Nishiyama, Hiroyuki;
- Clark, Jason;
- Munteanu, Mihaela;
- Kataria, Ritesh;
- Jia, Calvin;
- Powles, Thomas;
- Sternberg, Cora N.
Publication type:
Article
Checkpoint Inhibitors and Urothelial Carcinoma: The Translational Paradigm.
Published in:
Oncology (08909091), 2016, v. 30, n. 2, p. 160
By:
- Zibelman, Matthew;
- Plimack, Elizabeth R.
Publication type:
Article
Mechanisms of Immunotherapy Resistance in mCRPC: Identifying the Enemy on the Visceral Metastatic Battlefield.
Published in:
2014
By:
- Kim, Joseph W.;
- Bilusic, Marijo;
- Plimack, Elizabeth R.
Publication type:
Journal Article
Mechanisms of Immunotherapy Resistance in mCRPC: Identifying the Enemy on the Visceral Metastatic Battlefield.
Published in:
Oncology (08909091), 2014, v. 28, n. 11, p. 986
By:
- KIM, JOSEPH W.;
- BILUSIC, MARIJO;
- PLIMACK, ELIZABETH R.
Publication type:
Article
Update on Perioperative Systemic Therapy for Urothelial Carcinoma.
Published in:
Clinical Advances in Hematology & Oncology, 2019, v. 17, n. 3, p. 176
By:
- Rouvinov, Keren;
- Plimack, Elizabeth R.;
- Zibelman, Matthew;
- Ghatalia, Pooja;
- Geynisman, Daniel M.
Publication type:
Article
Evolving Landscape of the Treatment of Metastatic Clear Cell Renal Cell Carcinoma.
Published in:
Clinical Advances in Hematology & Oncology, 2018, v. 16, n. 10, p. 677
By:
- Ghatalia, Pooja;
- Zibelman, Matthew R.;
- Geynisman, Daniel M.;
- Plimack, Elizabeth R.
Publication type:
Article
Advanced small cell carcinoma of the bladder: clinical characteristics, treatment patterns and outcomes in 960 patients and comparison with urothelial carcinoma.
Published in:
Cancer Medicine, 2016, v. 5, n. 2, p. 192, doi. 10.1002/cam4.577
By:
- Geynisman, Daniel M.;
- Handorf, Elizabeth;
- Wong, Yu‐Ning;
- Doyle, Jamie;
- Plimack, Elizabeth R.;
- Horwitz, Eric M.;
- Canter, Daniel J.;
- Uzzo, Robert G.;
- Kutikov, Alexander;
- Smaldone, Marc C.
Publication type:
Article
Checkpoint Inhibitors for the Treatment of Renal Cell Carcinoma.
Published in:
2017
By:
- Ghatalia, Pooja;
- Zibelman, Matthew;
- Geynisman, Daniel;
- Plimack, Elizabeth;
- Geynisman, Daniel M;
- Plimack, Elizabeth R
Publication type:
journal article
Muscle-invasive urothelial bladder cancer: an update on systemic therapy.
Published in:
Therapeutic Advances in Urology, 2015, v. 7, n. 6, p. 312, doi. 10.1177/1756287215607418
By:
- Knollman, Hayley;
- Godwin, J. Luke;
- Jain, Rishi;
- Wong, Yu-Ning;
- Plimack, Elizabeth R.;
- Geynisman, Daniel M.
Publication type:
Article
Safety of neoadjuvant chemotherapy in patients with muscle‐invasive bladder cancer and malignant ureteric obstruction.
Published in:
BJU International, 2022, v. 129, n. 3, p. 364, doi. 10.1111/bju.15410
By:
- Strother, Marshall C.;
- Kutikov, Alexander;
- Epstein, Matthew;
- Bochner, Emily;
- Deng, Mengying;
- Handorf, Elizabeth;
- Lewis, Bianca;
- Ghatalia, Pooja;
- Greenberg, Richard E.;
- Chen, David;
- Viterbo, Rosalia;
- Anari, Fern;
- Smaldone, Marc C.;
- Zibelman, Matthew R.;
- Uzzo, Robert G.;
- Plimack, Elizabeth R.;
- Geynisman, Daniel M.
Publication type:
Article
Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study.
Published in:
BJU International, 2017, v. 120, n. 6, p. 782, doi. 10.1111/bju.13705
By:
- Shah, Amishi Y.;
- Karam, Jose A.;
- Malouf, Gabriel G.;
- Rao, Priya;
- Lim, Zita D.;
- Jonasch, Eric;
- Xiao, Lianchun;
- Gao, Jianjun;
- Vaishampayan, Ulka N.;
- Heng, Daniel Y.;
- Plimack, Elizabeth R.;
- Guancial, Elizabeth A.;
- Fung, Chunkit;
- Lowas, Stefanie R.;
- Tamboli, Pheroze;
- Sircar, Kanishka;
- Matin, Surena F.;
- Kimryn Rathmell, W.;
- Wood, Christopher G.;
- Tannir, Nizar M.
Publication type:
Article
Neoadjuvant vs. Adjuvant Chemotherapy in Muscle Invasive Bladder Cancer (MIBC): Analysis From the RISC Database.
Published in:
Frontiers in Oncology, 2018, p. N.PAG, doi. 10.3389/fonc.2018.00463
By:
- Del Bene, Gabriella;
- Calabrò, Fabio;
- Giannarelli, Diana;
- Plimack, Elizabeth R.;
- Harshman, Lauren C.;
- Yu, Evan Y.;
- Crabb, Simon J.;
- Pal, Sumanta Kumar;
- Alva, Ajjai S.;
- Powles, Thomas;
- De Giorgi, Ugo;
- Agarwal, Neeraj;
- Bamias, Aristotelis;
- Ladoire, Sylvain;
- Necchi, Andrea;
- Vaishampayan, Ulka N.;
- Niegisch, Günter;
- Bellmunt, Joaquim;
- Baniel, Jack;
- Galsky, Matthew D.
Publication type:
Article
Immunotherapy for Urothelial Carcinoma: Current Evidence and Future Directions.
Published in:
Current Urology Reports, 2018, v. 19, n. 12, p. 1, doi. 10.1007/s11934-018-0851-7
By:
- Tripathi, Abhishek;
- Plimack, Elizabeth R.
Publication type:
Article
Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer.
Published in:
Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-02320-7
By:
- Mouw, Kent;
- Liu, David;
- Keliher, Daniel;
- Reardon, Brendan;
- Miao, Diana;
- Stephanie Wankowicz, Stephanie Wankowicz;
- Han, Garam;
- Garraway, Levi A.;
- Carter, Scott L.;
- Bellmunt, Joaquim;
- Van Allen, Eliezer M.;
- Weiner-Taylor, Amaro;
- Kim, Jaegil;
- Getz, Gad;
- Abbosh, Philip;
- Dulaimi, Essel;
- Chen, David Y. T.;
- Katherine Alpaugh, R.;
- Plimack, Elizabeth R.;
- Min Yuen Teo
Publication type:
Article
Tumor downstaging as an intermediate endpoint to assess the activity of neoadjuvant systemic therapy in patients with muscle-invasive bladder cancer.
Published in:
2019
By:
- Martini, Alberto;
- Jia, Rachel;
- Ferket, Bart S.;
- Waingankar, Nikhil;
- Plimack, Elizabeth R.;
- Crabb, Simon J.;
- Harshman, Lauren C.;
- Yu, Evan Y.;
- Powles, Thomas;
- Rosenberg, Jonathan E.;
- Pal, Sumanta K.;
- Vaishampayan, Ulka N.;
- Necchi, Andrea;
- Wiklund, N. Peter;
- Mehrazin, Reza;
- Mazumdar, Madhu;
- Sfakianos, John P.;
- Galsky, Matthew D.
Publication type:
journal article
A phase 2, randomized trial evaluating the combination of dalantercept plus axitinib in patients with advanced clear cell renal cell carcinoma.
Published in:
2019
By:
- Voss, Martin H.;
- Bhatt, Rupal S.;
- Vogelzang, Nicholas J.;
- Fishman, Mayer;
- Alter, Robert S.;
- Rini, Brian I.;
- Beck, J. Thaddeus;
- Joshi, Monika;
- Hauke, Ralph;
- Atkins, Michael B.;
- Burgess, Earle;
- Logan, Theodore F.;
- Shaffer, David;
- Parikh, Rahul;
- Moazzam, Nauman;
- Zhang, Xiaosha;
- Glasser, Chad;
- Sherman, Matthew L.;
- Plimack, Elizabeth R.
Publication type:
journal article
Patterns of disease progression in metastatic renal cell carcinoma patients treated with antivascular agents and interferon: impact of therapy on recurrence patterns and outcome measures.
Published in:
2009
By:
- Plimack ER;
- Tannir N;
- Lin E;
- Bekele BN;
- Jonasch E;
- Plimack, Elizabeth R;
- Tannir, Nizar;
- Lin, E;
- Bekele, B Nebiyou;
- Jonasch, Eric
Publication type:
journal article
Patterns of Disease Progression in Metastatic Renal Cell Carcinoma Patients Treated With Antivascular Agents and Interferon.
Published in:
Cancer (0008543X), 2009, v. 115, n. 9, p. 1859, doi. 10.1002/cncr.24211
By:
- Plimack, Elizabeth R.;
- Tannir, Nizar;
- Lin, E.;
- Bekele, B. Nebiyou;
- Jonasch, Eric
Publication type:
Article
Association between baseline body mass index and survival in men with metastatic hormone‐sensitive prostate cancer: ECOG‐ACRIN CHAARTED E3805.
Published in:
Prostate, 2022, v. 82, n. 12, p. 1176, doi. 10.1002/pros.24369
By:
- Morgans, Alicia K.;
- Chen, Yu‐Hui;
- Jarrard, David F.;
- Carducci, Michael;
- Liu, Glenn;
- Eisenberger, Mario;
- Plimack, Elizabeth R.;
- Bryce, Alan;
- Garcia, Jorge A.;
- Dreicer, Robert;
- Vogelzang, Nicholas J.;
- Picus, Joel;
- Shevrin, Daniel;
- Hussain, Maha;
- DiPaola, Robert S.;
- Cella, David;
- Sweeney, Christopher J.
Publication type:
Article
Patients' Perceptions Regarding the Relevance of Items Contained in the Functional Assessment of Cancer Therapy Kidney Symptom Index-19.
Published in:
Oncologist, 2023, v. 28, n. 6, p. 494, doi. 10.1093/oncolo/oyad028
By:
- Bergerot, Cristiane Decat;
- Malhotra, Jasnoor;
- Bergerot, Paulo;
- Philip, Errol J;
- Castro, Daniela V;
- Hsu, JoAnn;
- Mota, Augusto Cesar de Andrade;
- Azeredo, Andressa Cardoso de;
- Neto, João Nunes de Matos;
- Hutson, Thomas;
- Grünwald, Viktor;
- Bex, Axel;
- Psutka, Sarah P;
- Rini, Brian;
- Plimack, Elizabeth R;
- Master, Viraj;
- Albiges, Laurence;
- Choueiri, Toni K;
- Pal, Sumanta;
- Powles, Thomas
Publication type:
Article
Comparative Effectiveness of Front-Line Ipilimumab and Nivolumab or Axitinib and Pembrolizumab in Metastatic Clear Cell Renal Cell Carcinoma.
Published in:
Oncologist, 2023, v. 28, n. 2, p. 157, doi. 10.1093/oncolo/oyac195
By:
- Zarrabi, Kevin K;
- Handorf, Elizabeth;
- Miron, Benjamin;
- Zibelman, Matthew R;
- Anari, Fern;
- Ghatalia, Pooja;
- Plimack, Elizabeth R;
- Geynisman, Daniel M
Publication type:
Article
The Impact of Cisplatin‐ or Non‐Cisplatin‐Containing Chemotherapy on Long‐Term and Conditional Survival of Patients with Advanced Urinary Tract Cancer.
Published in:
Oncologist, 2019, v. 24, n. 10, p. 1348, doi. 10.1634/theoncologist.2018-0739
By:
- Bamias, Aristotelis;
- Tzannis, Kimon;
- Bamia, Christina;
- Harshman, Lauren C.;
- Crabb, Simon;
- Plimack, Elizabeth R.;
- Pal, Sumanta;
- De Giorgi, Ugo;
- Ladoire, Sylvain;
- Theodore, Christine;
- Agarwal, Neeraj;
- Yu, Evan Y.;
- Niegisch, Guenter;
- Sternberg, Cora N.;
- Srinivas, Sandy;
- Vaishampayan, Ulka;
- Necchi, Andrea;
- Liontos, Michalis;
- Rosenberg, Jonathan E.;
- Powles, Thomas
Publication type:
Article
First‐in‐Human Phase I Study of Merestinib, an Oral Multikinase Inhibitor, in Patients with Advanced Cancer.
Published in:
Oncologist, 2019, v. 24, n. 9, p. e930, doi. 10.1634/theoncologist.2018-0411
By:
- He, Aiwu Ruth;
- Cohen, Roger B.;
- Denlinger, Crystal S.;
- Sama, Ashwin;
- Birnbaum, Ariel;
- Hwang, Jimmy;
- Sato, Takami;
- Lewis, Nancy;
- Mynderse, Michelle;
- Niland, Michele;
- Giles, Jennifer;
- Wallin, Johan;
- Moser, Brian;
- Zhang, Wei;
- Walgren, Richard;
- Plimack, Elizabeth R.
Publication type:
Article
Efficacy of Split Schedule Versus Conventional Schedule Neoadjuvant Cisplatin‐Based Chemotherapy for Muscle‐Invasive Bladder Cancer.
Published in:
Oncologist, 2019, v. 24, n. 5, p. 688, doi. 10.1634/theoncologist.2018-0561
By:
- Osterman, Chelsea K.;
- Babu, Dilip S.;
- Geynisman, Daniel M.;
- Lewis, Bianca;
- Somer, Robert A.;
- Balar, Arjun V.;
- Zibelman, Matthew R.;
- Guancial, Elizabeth A.;
- Antinori, Gianna;
- Yu, Shun;
- Narayan, Vivek;
- Guzzo, Thomas J.;
- Plimack, Elizabeth R.;
- Vaughn, David J.;
- Fung, Chunkit;
- Mamtani, Ronac
Publication type:
Article
Immune-Related Adverse Events as a Biomarker in Non-Melanoma Patients Treated with Programmed Cell Death 1 Inhibitors.
Published in:
Oncologist, 2017, v. 22, n. 10, p. 1232, doi. 10.1634/theoncologist.2017-0133
By:
- Judd, Julia;
- Zibelman, Matthew;
- Handorf, Elizabeth;
- O'Neill, John;
- Ramamurthy, Chethan;
- Bentota, Sasini;
- Doyle, Jamie;
- Uzzo, Robert G.;
- Bauman, Jessica;
- Borghaei, Hossein;
- Plimack, Elizabeth R.;
- Mehra, Ranee;
- Geynisman, Daniel M.
Publication type:
Article
A Phase I Study of Temsirolimus and Bryostatin-1 in Patients With Metastatic Renal Cell Carcinoma and Soft Tissue Sarcoma.
Published in:
Oncologist, 2014, v. 19, n. 4, p. 354, doi. 10.1634/theoncologist.2014-0020
By:
- Plimack, Elizabeth R.;
- Tan, Tingting;
- Wong, Yu‐Ning;
- Mehren, Margaret M.;
- Malizzia, Lois;
- Roethke, Susan K.;
- Litwin, Samuel;
- Li, Tianyu;
- Hudes, Gary R.;
- Haas, Naomi B.
Publication type:
Article
AZD1480: A Phase I Study of a Novel JAK2 Inhibitor in Solid Tumors.
Published in:
Oncologist, 2013, v. 18, n. 7, p. 819, doi. 10.1634/theoncologist.2013-0198
By:
- Plimack, Elizabeth R.;
- LoRusso, Patricia M.;
- McCoon, Patricia;
- Tang, Weifeng;
- Krebs, Annetta D.;
- Curt, Gregory;
- Eckhardt, S. Gail
Publication type:
Article
Measuring the Efficacy and Value of Urothelial Cancer Urinary Biomarkers.
Published in:
2015
By:
- Abbosh, Phillip H.;
- Plimack, Elizabeth R.
Publication type:
commentary
Comparative cost‐effectiveness of neoadjuvant chemotherapy regimens for muscle‐invasive bladder cancer: Results according to VESPER data.
Published in:
Cancer (0008543X), 2022, v. 128, n. 24, p. 4194, doi. 10.1002/cncr.34502
By:
- Joyce, Daniel D.;
- Wymer, Kevin M.;
- Sharma, Vidit;
- Moriarty, James P.;
- Borah, Bijan J.;
- Geynisman, Daniel M.;
- Plimack, Elizabeth R.;
- Costello, Brian A.;
- Pagliaro, Lance C.;
- Boorjian, Stephen A.
Publication type:
Article
Conditional survival and long‐term efficacy with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma.
Published in:
Cancer (0008543X), 2022, v. 128, n. 11, p. 2085, doi. 10.1002/cncr.34180
By:
- Motzer, Robert J.;
- McDermott, David F.;
- Escudier, Bernard;
- Burotto, Mauricio;
- Choueiri, Toni K.;
- Hammers, Hans J.;
- Barthélémy, Philippe;
- Plimack, Elizabeth R.;
- Porta, Camillo;
- George, Saby;
- Powles, Thomas;
- Donskov, Frede;
- Gurney, Howard;
- Kollmannsberger, Christian K.;
- Grimm, Marc‐Oliver;
- Barrios, Carlos;
- Tomita, Yoshihiko;
- Castellano, Daniel;
- Grünwald, Viktor;
- Rini, Brian I.
Publication type:
Article
Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long-term follow-up of the randomized, open-label, phase 3 CheckMate 025 trial.
Published in:
2020
By:
- Motzer, Robert J.;
- Escudier, Bernard;
- George, Saby;
- Hammers, Hans J.;
- Srinivas, Sandhya;
- Tykodi, Scott S.;
- Sosman, Jeffrey A.;
- Plimack, Elizabeth R.;
- Procopio, Giuseppe;
- McDermott, David F.;
- Castellano, Daniel;
- Choueiri, Toni K.;
- Donskov, Frede;
- Gurney, Howard;
- Oudard, Stéphane;
- Richardet, Martin;
- Peltola, Katriina;
- Alva, Ajjai S.;
- Carducci, Michael;
- Wagstaff, John
Publication type:
journal article
Complications of Targeted Therapies for Renal Cell Carcinoma.
Published in:
AUANews, 2009, v. 14, n. 12, p. 8
By:
- Plimack, Elizabeth R.;
- Uzzo, Robert
Publication type:
Article

Found: 39